Data
Five AI-enhanced clinical trial start-ups to watch in 2021
Artificial intelligence (AI) is increasingly being employed to improve the operational efficiency of clinical trials, accelerate drug discovery and minimise…
GDPR: The Implications for Clinical Development
For those based in Europe, the General Data Protection Regulation (GDPR) came into force across the European Union on May…
New Data Suggest HCV Remains a Problem in the US
New data from the Centers for Disease Control and Prevention (CDC)’s National Health and Nutrition Survey (NHANES) suggest that hepatitis…
Industry Viewpoints: The Challenges of Clinical Data Management
Sarah Fal: Who is involved in the clinical data management process? Kumar Komuravelli: In general, it tends to be clinical…
How Can Blockchain Disrupt the Pharma Industry?
In the last few years, blockchain and cryptocurrencies have been all the rage, particularly in the financial services industry. When…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
Since its launch in 2010, Moderna Therapeutics has become as famous for its valuation as it has for the secrecy…
Industry Viewpoints: Leveraging eSource in Data Management
With numerous technologies beginning to disrupt the ways in which data are collected and generated, Sarah Fal speaks to Terry…
Perfect Communication? That’s an Oxymoron!
Relationships in general are complicated and require constant massaging and manipulation. Anyone in clinical research, knows that the relationship between…
Enriched Evidence Generation: Linking Clinical Data, Registries and Patient-Reported Outcomes to Health Care Utilization
Real world data (RWD) are playing an increasing role in health care decisions. Combining various datasets provides complementary insights and…
Expert Insights: Another Failure for BACE1 Drugs Raises Questions about Alzheimer’s Disease Treatments
Johnson & Johnson’s Janssen division has decided to halt the Phase II–III EARLY clinical trial (NCT02569398) of its Alzheimer’s disease…